FollowTheFilings
Managers
Activity
Compare
Newest
Holders
MILESTONE PHARMACEUTICALS IN
Q4 2024 13F holders
CUSIP
59935V107
Type
Equity
Class
COM
Total Reported Value ($000, excl. options)
Manager
Report date
Value ($000)
Shares
Option type